Tae Min Kim Selected Research

Kraft lignin

7/2021

Formation of pure nanoparticles with solvent-fractionated lignin polymers and evaluation of their biocompatibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae Min Kim Research Topics

Disease

91	Neoplasms (Cancer) 04/2022 - 03/2008
63	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2011
21	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2011
19	Lymphoma (Lymphomas) 01/2022 - 12/2012
15	Neoplasm Metastasis (Metastasis) 06/2021 - 03/2008
12	Glioma (Gliomas) 04/2022 - 02/2011
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 03/2013
11	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2012
10	Squamous Cell Carcinoma of Head and Neck 11/2019 - 07/2013
8	Disease Progression 01/2022 - 01/2016
7	Adenocarcinoma 01/2019 - 05/2011
6	Brain Neoplasms (Brain Tumor) 04/2022 - 01/2015
6	Melanoma (Melanoma, Malignant) 01/2020 - 11/2015
5	Diarrhea 04/2022 - 09/2014
5	Adenocarcinoma of Lung 02/2021 - 04/2011
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 07/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 06/2021 - 10/2013
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2021 - 06/2016
3	Infections 01/2022 - 04/2015
3	Pneumonia (Pneumonitis) 01/2021 - 12/2013
3	Carcinoma (Carcinomatosis) 12/2020 - 01/2015
3	Astrocytoma (Pilocytic Astrocytoma) 04/2020 - 04/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2019 - 10/2015
3	Stomatitis 07/2018 - 09/2014
3	Extranodal NK-T-Cell Lymphoma 07/2018 - 07/2011
3	Exanthema (Rash) 07/2018 - 12/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 06/2016 - 12/2014
2	Fatigue 04/2022 - 09/2014
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 09/2015
2	Diabetes Mellitus 12/2021 - 01/2016
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2017
2	Febrile Neutropenia 12/2020 - 12/2012
2	Human Influenza (Influenza) 11/2020 - 03/2017
2	Liver Diseases (Liver Disease) 02/2020 - 01/2017
2	Pruritus (Itching) 04/2019 - 07/2018

Drug/Important Bio-Agent (IBA)

28	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2011
26	Tyrosine Kinase InhibitorsIBA 02/2021 - 05/2011
21	Temozolomide (Temodar)FDA LinkGeneric 04/2022 - 07/2011
17	Anaplastic Lymphoma KinaseIBA 01/2022 - 05/2011
13	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2016
11	LigandsIBA 10/2021 - 09/2015
11	Gefitinib (Iressa)FDA Link 01/2018 - 07/2013
10	Rituximab (Mabthera)FDA Link 01/2022 - 09/2013
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
9	Biomarkers (Surrogate Marker)IBA 10/2021 - 09/2011
9	CrizotinibIBA 09/2019 - 06/2012
8	PlatinumIBA 12/2021 - 08/2012
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 11/2014
6	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 12/2012
6	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 08/2011
6	Pemetrexed (MTA)FDA Link 01/2019 - 09/2011
5	RNA (Ribonucleic Acid)IBA 06/2021 - 01/2016
5	B7-H1 AntigenIBA 02/2021 - 11/2017
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
5	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 07/2014
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 11/2014
5	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 07/2011
4	dabrafenibIBA 01/2022 - 01/2016
4	trametinibIBA 01/2022 - 07/2016
4	pembrolizumabIBA 01/2021 - 01/2019
4	Etoposide (VP 16)FDA LinkGeneric 10/2019 - 11/2014
4	Ifosfamide FDA LinkGeneric 07/2018 - 12/2013
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 08/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2012
4	Sunitinib (Sutent)FDA Link 09/2014 - 08/2011
3	Phosphotransferases (Kinase)IBA 01/2022 - 05/2015
3	Biological ProductsIBA 01/2022 - 02/2016
3	BI 836826IBA 02/2021 - 10/2020
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2015
3	N-acetoacetyl-N-deacetylcolchicineIBA 01/2021 - 01/2014
3	Brentuximab VedotinIBA 01/2021 - 06/2015
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 07/2016
3	Docetaxel (Taxotere)FDA Link 01/2017 - 10/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 09/2011
3	Prednisone (Sone)FDA LinkGeneric 07/2015 - 11/2014
3	Gemcitabine FDA Link 01/2015 - 08/2012
3	MethyltransferasesIBA 04/2013 - 10/2012
2	polatuzumab vedotinIBA 01/2022 - 10/2020
2	pazopanib FDA Link 10/2021 - 01/2019
2	osimertinibIBA 01/2020 - 12/2015
2	Monoclonal AntibodiesIBA 01/2020 - 01/2019
2	NucleotidesIBA 01/2020 - 01/2020
2	NivolumabIBA 12/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2019 - 04/2011
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 03/2013
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
30	Therapeutics 11/2021 - 05/2010
24	Radiotherapy 04/2022 - 07/2011
22	Chemoradiotherapy 04/2022 - 02/2011
7	Immunotherapy 01/2022 - 09/2015
6	Induction Chemotherapy 07/2016 - 07/2013
5	Aftercare (After-Treatment) 11/2019 - 03/2014
4	Adjuvant Chemotherapy 01/2022 - 03/2008
4	Combination Drug Therapy (Combination Chemotherapy) 01/2015 - 07/2004
3	Transplantation 10/2020 - 07/2006
2	Adjuvant Radiotherapy 01/2022 - 01/2021
2	Kidney Transplantation 12/2021 - 12/2016
2	Metastasectomy 06/2021 - 01/2019
2	Drug Tapering 12/2020 - 12/2014